Replies to post #136961 on Biotech Values

[jbog]

mcbio,

I originally thought M118 or M402 would have been much more profitable from a shareholders perspective.

Now that M118 is shelved, it's up to M402 to carry the day. Maybe the new acquisition can spark something.

I only hoped that Enox or Copax would pay the way. How much excitement can we expect from 20 year old drugs.

Good Luck